We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Walgreens Boots Alliance (WBA) Stock Sinks As Market Gains: What You Should Know
Read MoreHide Full Article
Walgreens Boots Alliance (WBA - Free Report) closed the most recent trading day at $71.88, moving -0.53% from the previous trading session. This change lagged the S&P 500's 0.09% gain on the day. Elsewhere, the Dow gained 0.26%, while the tech-heavy Nasdaq lost 0.25%.
Prior to today's trading, shares of the largest U.S. drugstore chain had gained 7.32% over the past month. This has lagged the Retail-Wholesale sector's gain of 10.7% and the S&P 500's gain of 7.92% in that time.
Wall Street will be looking for positivity from WBA as it approaches its next earnings report date. This is expected to be March 27, 2019. The company is expected to report EPS of $1.74, up 0.58% from the prior-year quarter. Meanwhile, our latest consensus estimate is calling for revenue of $34.72 billion, up 5.16% from the prior-year quarter.
WBA's full-year Zacks Consensus Estimates are calling for earnings of $6.52 per share and revenue of $136.85 billion. These results would represent year-over-year changes of +8.31% and +4.04%, respectively.
Investors might also notice recent changes to analyst estimates for WBA. These revisions typically reflect the latest short-term business trends, which can change frequently. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. WBA is currently sporting a Zacks Rank of #3 (Hold).
In terms of valuation, WBA is currently trading at a Forward P/E ratio of 11.08. For comparison, its industry has an average Forward P/E of 11.08, which means WBA is trading at a no noticeable deviation to the group.
We can also see that WBA currently has a PEG ratio of 1.13. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. The Retail - Pharmacies and Drug Stores industry currently had an average PEG ratio of 1.05 as of yesterday's close.
The Retail - Pharmacies and Drug Stores industry is part of the Retail-Wholesale sector. This industry currently has a Zacks Industry Rank of 110, which puts it in the top 44% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks. Com to follow all of these stock-moving metrics, and more, in the coming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Walgreens Boots Alliance (WBA) Stock Sinks As Market Gains: What You Should Know
Walgreens Boots Alliance (WBA - Free Report) closed the most recent trading day at $71.88, moving -0.53% from the previous trading session. This change lagged the S&P 500's 0.09% gain on the day. Elsewhere, the Dow gained 0.26%, while the tech-heavy Nasdaq lost 0.25%.
Prior to today's trading, shares of the largest U.S. drugstore chain had gained 7.32% over the past month. This has lagged the Retail-Wholesale sector's gain of 10.7% and the S&P 500's gain of 7.92% in that time.
Wall Street will be looking for positivity from WBA as it approaches its next earnings report date. This is expected to be March 27, 2019. The company is expected to report EPS of $1.74, up 0.58% from the prior-year quarter. Meanwhile, our latest consensus estimate is calling for revenue of $34.72 billion, up 5.16% from the prior-year quarter.
WBA's full-year Zacks Consensus Estimates are calling for earnings of $6.52 per share and revenue of $136.85 billion. These results would represent year-over-year changes of +8.31% and +4.04%, respectively.
Investors might also notice recent changes to analyst estimates for WBA. These revisions typically reflect the latest short-term business trends, which can change frequently. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. WBA is currently sporting a Zacks Rank of #3 (Hold).
In terms of valuation, WBA is currently trading at a Forward P/E ratio of 11.08. For comparison, its industry has an average Forward P/E of 11.08, which means WBA is trading at a no noticeable deviation to the group.
We can also see that WBA currently has a PEG ratio of 1.13. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. The Retail - Pharmacies and Drug Stores industry currently had an average PEG ratio of 1.05 as of yesterday's close.
The Retail - Pharmacies and Drug Stores industry is part of the Retail-Wholesale sector. This industry currently has a Zacks Industry Rank of 110, which puts it in the top 44% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks. Com to follow all of these stock-moving metrics, and more, in the coming trading sessions.